As of January 22, 2025, Rafael Holdings (RFL) has a market cap of $51.221 million USD. According to our data, Rafael Holdings is ranked No.8139 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $51.22 M |
-5.70%
|
Dec 31, 2024 | $54.32 M |
-9.84%
|
Dec 29, 2023 | $60.24 M |
-2.14%
|
Dec 30, 2022 | $61.56 M |
-63.33%
|
Dec 31, 2021 | $0.17 B |
-78.13%
|
Dec 31, 2020 | $0.77 B |
30.72%
|
Dec 31, 2019 | $0.59 B |
124.97%
|
Dec 31, 2018 | $0.26 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Fortress Biotech
FBIO
|
$49.96 M |
0.000 M
|
USA
|
Verastem Oncology
VSTM
|
$0.25 B |
-0.000 M
|
USA
|
Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
TG Therapeutics
TGTX
|
$4.54 B |
0.000 M
|
USA
|
Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Market Cap | = | RFL Stock Price | * | RFL Shares Outstanding |
= | $2.07 | * | 23.96 M | |
= | $51.22 M |